Want to see TSE:DRUG full AI Analyst Report?
Bright Minds Biosciences (DRUG) Financial Statements
77 Followers
Bright Minds Biosciences Financial Overview
Bright Minds Biosciences's market cap is currently C$262.25M. The company's EPS TTM is C$-2.76; its P/E ratio is -8.96; Bright Minds Biosciences is estimated to report earnings on December 17, 2026, and the estimated EPS forecast is C$-1.63. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Dec 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Operating Income | C$ -13.94M | C$ -2.82M | C$ -7.39M | C$ -14.98M | C$ -8.62M |
| EBITDA | C$ -12.15M | C$ -2.73M | C$ -7.30M | C$ -14.96M | C$ -27.64K |
| Net Income | C$ -12.23M | C$ -2.80M | C$ -7.37M | C$ -14.96M | C$ -8.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 82.91M | C$ 5.72M | C$ 6.75M | C$ 11.63M | C$ 19.76M |
| Total Assets | C$ 84.42M | C$ 6.10M | C$ 6.88M | C$ 12.09M | C$ 20.04M |
| Total Debt | C$ 125.78K | C$ 118.96K | C$ 73.55K | C$ 139.91K | C$ 0.00 |
| Net Debt | C$ -82.78M | C$ -5.60M | C$ -6.67M | C$ -11.49M | C$ -19.76M |
| Total Liabilities | C$ 2.38M | C$ 568.26K | C$ 280.86K | C$ 1.54M | C$ 638.57K |
| Stockholders' Equity | C$ 82.04M | C$ 5.54M | C$ 6.60M | C$ 10.54M | C$ 19.40M |
| Cash Flow | |||||
| Free Cash Flow | C$ -8.69M | C$ -1.85M | C$ -7.02M | C$ -13.59M | C$ -7.32M |
| Operating Cash Flow | C$ -8.69M | C$ -1.85M | C$ -7.02M | C$ -13.59M | C$ -7.32M |
| Investing Cash Flow | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Financing Cash Flow | C$ 85.57M | C$ 810.57K | C$ 2.19M | C$ 5.20M | C$ 26.06M |
Currency in CAD
